Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 28 January 2015
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 28 January 2015. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(continuation of news of BXPHARMA): will be drawn down in four tranches against delivery and installation of the plant and machinery commencing now and due for completion in June 2016, with commissioning to be completed by September 2016. The Loan will attract interest at the rate of 2.25% per annum above LIBOR; in addition, the Lender will receive management fees and commitment fees. Repayment will be made over five years, in 10 semi-annual payments commencing for US $5.597 million from the (cont.2)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf4d5a6b00004006521c
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.